Endologix

Endologix, founded in 1992, focuses on providing innovative minimally invasive technologies for aortic diseases. The company’s current product portfolio includes various endovascular stent grafts for the treatment of abdominal aortic aneurysms (AAA) and is protected by more than 108 patents. Endologix is committed to addressing unmet needs in aortic therapies and continuously strives to deliver breakthrough and effective solutions for physicians and their patients. With cutting-edge technology, the company envisions offering the best medical devices for every patient; because when it comes to ensuring patient health, Endologix will never settle for the status quo.